McKESSON CORPORATION MCK Cash Flow

Mckesson corporation (MCK)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09	Dec'08	Sep'08	Jun'08
Operating Activities
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
1,078,000	242,000	-677,000	477,000	-744,000	526,000	553,000	-80,000	-1,085,000	961,000	56,000	365,000	3,623,000	646,000	324,000	560,000	444,000	647,000	630,000	589,000	144,000	511,000	477,000	411,000	365,000	65,000	404,000	424,000	259,000	298,000	401,000	380,000	521,000	300,000	296,000	286,000	422,000	155,000	327,000	298,000	348,000	326,000	301,000	288,000	281,000	-20,000	327,000	235,000
Adjustments to reconcile to net cash provided by operating activities:
Gain (Loss) on Disposition of Business
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	51,000	51,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
-	228,000	234,000	229,000	-	239,000	240,000	235,000	-	234,000	236,000	227,000	-	204,000	217,000	242,000	-	220,000	222,000	229,000	-	248,000	258,000	280,000	-	163,000	170,000	162,000	-	131,000	127,000	125,000	-	137,000	136,000	135,000	-	114,000	118,000	120,000	-	126,000	113,000	111,000	-	112,000	112,000	106,000
Asset Impairment Charges
-	101,000	7,000	5,000	-	60,000	1,000	610,000	-	0	539,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred taxes
-45,000	7,000	396,000	-16,000	-19,000	-110,000	-15,000	-45,000	21,000	889,000	43,000	-85,000	-760,000	-212,000	121,000	-31,000	-34,000	-7,000	0	-23,000	-97,000	40,000	24,000	-138,000	69,000	65,000	-53,000	-98,000	-116,000	-101,000	-128,000	-270,000	-190,000	41,000	5,000	-31,000	-	-	-	-	-	-	-	-	-	-	52,000	10,000
Share-based compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	41,000	35,000	39,000	39,000	38,000	33,000	33,000	33,000	31,000	30,000	29,000	24,000	27,000	19,000	25,000	28,000
Gain on business combination
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	81,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Credits associated with last-in, first-out inventory method
-138,000	-66,000	-33,000	-15,000	-146,000	-21,000	-22,000	-21,000	-94,000	-2,000	-29,000	26,000	144,000	-155,000	-43,000	47,000	29,000	33,000	91,000	91,000	50,000	95,000	94,000	98,000	125,000	142,000	44,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity earnings and charges from investment in Change Healthcare Joint Venture
-	-28,000	-1,454,000	4,000	-	-50,000	-56,000	-56,000	-	-90,000	-61,000	-120,000	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss (gain) from sales of businesses and investments
-	-	-	-	-	-	-	-	-	-	-	-	19,000	0	0	-113,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-cash items
-73,000	-398,000	-23,000	-121,000	-147,000	-43,000	59,000	79,000	-142,000	57,000	25,000	-7,000	-153,000	-45,000	24,000	-29,000	31,000	-132,000	13,000	-20,000	-98,000	75,000	-11,000	-13,000	-47,000	-65,000	14,000	-32,000	-41,000	-28,000	16,000	-37,000	-18,000	-49,000	-18,000	-8,000	46,000	23,000	-69,000	-12,000	-46,000	-34,000	22,000	78,000	-92,000	1,000	-4,000	-4,000
Changes in assets and liabilities, net of acquisitions:
Receivables
1,450,000	178,000	-195,000	1,061,000	-576,000	-162,000	291,000	1,414,000	-2,221,000	234,000	449,000	363,000	108,000	-3,000	357,000	300,000	290,000	630,000	288,000	749,000	6,000	1,284,000	838,000	693,000	-7,000	482,000	254,000	139,000	-251,000	144,000	237,000	-448,000	193,000	140,000	240,000	195,000	475,000	53,000	317,000	-172,000	-282,000	466,000	250,000	-301,000	1,589,000	-544,000	-26,000	-311,000
Impact of accounts receivable sales facility
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-147,000	172,000	325,000
Inventories
-313,000	1,020,000	-186,000	-145,000	-388,000	358,000	284,000	114,000	-952,000	193,000	1,158,000	59,000	-694,000	536,000	-283,000	121,000	-1,146,000	928,000	834,000	635,000	-436,000	1,458,000	229,000	893,000	-205,000	1,152,000	175,000	60,000	-253,000	332,000	-23,000	4,000	-318,000	931,000	-34,000	303,000	-345,000	640,000	-690,000	28,000	577,000	229,000	-66,000	42,000	120,000	-321,000	103,000	-272,000
Drafts and accounts payable
4,881,000	274,000	-1,330,000	127,000	1,801,000	-1,022,000	1,165,000	32,000	-932,000	-605,000	1,345,000	463,000	179,000	-281,000	623,000	1,549,000	1,607,000	-265,000	957,000	1,003,000	644,000	2,611,000	96,000	1,367,000	1,831,000	237,000	-245,000	589,000	953,000	-454,000	309,000	-933,000	401,000	756,000	435,000	445,000	481,000	469,000	-497,000	80,000	209,000	320,000	455,000	356,000	-573,000	367,000	-312,000	329,000
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	196,000	-141,000	-113,000	-54,000	192,000	-132,000	-126,000	-122,000	234,000	-119,000	-134,000	-69,000	220,000	-116,000	-116,000	-116,000	-106,000	262,000	-84,000	-25,000	-69,000	241,000	-50,000	-40,000	260,000	-109,000	-69,000	-30,000	251,000	-110,000	-84,000	-143,000	240,000	-99,000	-53,000
Taxes
-19,000	-59,000	-12,000	82,000	36,000	-32,000	-38,000	-61,000	-18,000	603,000	104,000	-18,000	94,000	-99,000	56,000	95,000	-192,000	-89,000	-2,000	205,000	-19,000	-137,000	68,000	-134,000	67,000	148,000	-28,000	31,000	-8,000	28,000	24,000	-142,000	-152,000	42,000	86,000	43,000	-	-	-	-	-	-	-	-	-154,000	59,000	-14,000	62,000
Deferred tax expense (benefit) on litigation charges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-41,000	2,000	-	-	-	-	-	-	-	-	-	-	-	-
Other
25,000	60,000	-250,000	173,000	-229,000	-66,000	-43,000	270,000	-1,000	-229,000	39,000	112,000	184,000	-116,000	117,000	273,000	-181,000	38,000	-139,000	145,000	108,000	-308,000	-113,000	271,000	191,000	-324,000	-155,000	305,000	-18,000	-253,000	-13,000	295,000	-15,000	-137,000	48,000	109,000	104,000	-110,000	60,000	90,000	-24,000	-122,000	0	125,000	100,000	95,000	-37,000	-141,000
Payments for Legal Settlements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,000	32,000	165,000	273,000	0	20,000	0	6,000	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities
4,654,000	-121,000	-108,000	-51,000	3,895,000	-177,000	1,379,000	-1,061,000	3,024,000	-18,000	598,000	741,000	1,435,000	381,000	1,069,000	1,859,000	3,106,000	-685,000	797,000	454,000	1,883,000	1,064,000	-17,000	182,000	2,664,000	-341,000	97,000	716,000	2,207,000	-183,000	1,011,000	-552,000	1,234,000	321,000	1,069,000	326,000	1,000,000	540,000	270,000	528,000	591,000	192,000	626,000	907,000	617,000	186,000	234,000	314,000
Investing Activities
Payments for property, plant and equipment
120,000	116,000	39,000	87,000	117,000	131,000	77,000	101,000	136,000	105,000	89,000	75,000	158,000	95,000	75,000	76,000	216,000	94,000	101,000	77,000	95,000	91,000	107,000	83,000	87,000	58,000	64,000	69,000	96,000	62,000	38,000	45,000	51,000	44,000	68,000	58,000	76,000	50,000	55,000	52,000	62,000	44,000	51,000	42,000	44,000	71,000	40,000	40,000
Capitalized software expenditures
48,000	38,000	34,000	24,000	35,000	26,000	26,000	44,000	52,000	32,000	48,000	43,000	35,000	34,000	51,000	38,000	44,000	49,000	53,000	43,000	51,000	38,000	47,000	33,000	33,000	42,000	34,000	32,000	48,000	36,000	42,000	33,000	40,000	36,000	50,000	51,000	44,000	36,000	40,000	35,000	45,000	38,000	52,000	44,000	60,000	47,000	52,000	38,000
Payments to Acquire Businesses, Net of Cash Acquired
36,000	2,000	49,000	46,000	39,000	26,000	14,000	826,000	914,000	105,000	389,000	1,485,000	38,000	2,133,000	222,000	1,819,000	15,000	14,000	5,000	6,000	130,000	9,000	17,000	14,000	4,518,000	0	42,000	74,000	1,296,000	326,000	143,000	108,000	847,000	10,000	88,000	106,000	-	-	-	-	-	-	-	-	38,000	0	78,000	242,000
Proceeds from sale of businesses and investments, net and Payments received on Healthcare Technology Net Asset Exchange, net
-	-	-	-	-	-	-	-	-	-	-	-	115,000	-7,000	-3,000	101,000	-	0	120,000	84,000	0	17,000	-2,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash for acquisitions
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-935,000	939,000	0	18,000	-18,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
3,000	-32,000	34,000	-28,000	140,000	-15,000	-9,000	-96,000	-16,000	10,000	31,000	-5,000	7,000	18,000	-153,000	55,000	121,000	2,000	-5,000	-7,000	-38,000	11,000	22,000	-18,000	32,000	145,000	-50,000	9,000	-15,000	9,000	-22,000	-36,000	134,000	-9,000	-11,000	-61,000	38,000	27,000	-4,000	-8,000	-	-	-	-	61,000	-39,000	-79,000	42,000
Net cash used in investing activities
-170,000	-124,000	-156,000	-129,000	-230,000	-168,000	-108,000	-875,000	-1,041,000	-87,000	-267,000	-1,598,000	350,000	-2,273,000	-192,000	-1,154,000	-1,329,000	-159,000	-52,000	-17,000	-238,000	-132,000	-195,000	-112,000	-4,624,000	-148,000	-90,000	-184,000	-1,425,000	-433,000	-201,000	-150,000	-1,072,000	-81,000	-195,000	-154,000	-158,000	-371,000	-16,000	-79,000	-106,000	-11,000	-106,000	-86,000	-195,000	-79,000	-91,000	-362,000
Financing Activities
Proceeds from short-term borrowings
5,585,000	7,182,000	6,060,000	2,610,000	6,873,000	10,657,000	10,699,000	9,036,000	7,843,000	4,235,000	6,182,000	2,282,000	5,491,000	2,793,000	3,000	7,000	29,000	31,000	970,000	531,000	676,000	634,000	885,000	905,000	5,930,000	0	50,000	100,000	1,100,000	0	1,125,000	0	-	-	-	-	-	-	-	-	-	-	-	-	28,000	70,000	2,974,000	558,000
Repayments of short-term borrowings
7,694,000	5,621,000	5,512,000	2,610,000	7,922,000	11,004,000	11,337,000	7,005,000	8,592,000	3,790,000	5,880,000	2,463,000	6,719,000	1,388,000	3,000	14,000	20,000	167,000	967,000	534,000	832,000	748,000	825,000	747,000	5,982,000	0	50,000	100,000	1,100,000	0	1,125,000	400,000	0	0	0	0	-	-	-	-	-	-	-	-	-7,232,000	70,000	2,974,000	558,000
Proceeds from issuances of long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-3,000	6,000	4,124,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of long-term debt
-	-	-	-	-	-	-	-	1,742,000	0	4,000	541,000	1,993,000	-386,000	-5,000	-1,000	602,000	498,000	594,000	-96,000	120,000	2,000	3,000	228,000	348,000	0	0	0	-	-	-	-	407,000	6,000	1,000	16,000	-	-	-	-	-	-	-	-	-	-	-	-
Common stock transactions:
Issuances
24,000	11,000	56,000	22,000	29,000	8,000	16,000	22,000	18,000	31,000	56,000	27,000	31,000	14,000	39,000	36,000	26,000	25,000	34,000	38,000	37,000	49,000	32,000	34,000	27,000	31,000	69,000	50,000	54,000	32,000	37,000	43,000	45,000	40,000	31,000	51,000	-	-	-	-	-	-	-	-	-	-	-	-
Share repurchases, including shares surrendered for tax withholding
3,000	499,000	751,000	701,000	251,000	500,000	581,000	307,000	758,000	250,000	401,000	300,000	251,000	2,002,000	0	58,000	652,000	355,000	500,000	105,000	344,000	1,000	3,000	102,000	2,000	0	1,000	127,000	801,000	360,000	0	53,000	1,202,000	0	0	672,000	502,000	1,000	531,000	1,016,000	1,000	0	24,000	298,000	-	0	0	147,000
Common stock issuances
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50,000	144,000	-	-	-	-31,000	-	-2,000	27,000	-35,000
Dividends paid
72,000	74,000	73,000	75,000	76,000	77,000	68,000	71,000	70,000	71,000	59,000	62,000	61,000	63,000	63,000	66,000	65,000	65,000	55,000	59,000	56,000	56,000	56,000	59,000	60,000	55,000	46,000	53,000	47,000	47,000	47,000	53,000	49,000	49,000	50,000	47,000	45,000	46,000	47,000	33,000	33,000	32,000	32,000	34,000	33,000	33,000	33,000	17,000
Other
-22,000	-50,000	-111,000	-118,000	-85,000	-64,000	-72,000	-134,000	-46,000	-30,000	-35,000	-74,000	-30,000	1,000	-3,000	14,000	78,000	-28,000	-67,000	22,000	-77,000	40,000	-28,000	24,000	3,000	-12,000	14,000	57,000	-7,000	-2,000	2,000	38,000	5,000	3,000	3,000	16,000	14,000	-17,000	55,000	2,000	42,000	-15,000	15,000	-2,000	6,000	-1,000	0	-1,000
Net cash used in financing activities
-2,480,000	949,000	-331,000	-872,000	-2,544,000	119,000	-1,343,000	1,541,000	-1,937,000	125,000	-141,000	-1,131,000	-924,000	-1,031,000	-32,000	-82,000	-1,206,000	-1,057,000	-987,000	-203,000	-716,000	-84,000	-1,000	-167,000	3,692,000	-36,000	36,000	-73,000	-1,038,000	515,000	-8,000	-425,000	-1,208,000	-12,000	-17,000	-668,000	-445,000	-20,000	-473,000	-903,000	-184,000	30,000	36,000	-303,000	527,000	-20,000	-199,000	-130,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-46,000	5,000	4,000	18,000	11,000	-43,000	-9,000	-78,000	7,000	34,000	34,000	75,000	15,000	-107,000	-40,000	-12,000	71,000	-52,000	-34,000	60,000	-175,000	-65,000	-88,000	9,000	30,000	-4,000	12,000	-10,000	-14,000	-4,000	16,000	-9,000	4,000	20,000	-30,000	0	2,000	14,000	4,000	-12,000	2,000	2,000	15,000	17,000	-15,000	-35,000	-8,000	3,000
Net increase (decrease) in cash, cash equivalents and restricted cash
1,958,000	709,000	-591,000	-1,034,000	1,132,000	-269,000	-81,000	-473,000	53,000	54,000	224,000	-1,913,000	876,000	-3,030,000	805,000	611,000	642,000	-1,953,000	-276,000	294,000	754,000	783,000	-301,000	-88,000	1,762,000	-529,000	55,000	449,000	-270,000	-105,000	818,000	-1,136,000	-1,042,000	248,000	827,000	-496,000	399,000	163,000	-215,000	-466,000	303,000	213,000	571,000	535,000	934,000	52,000	-64,000	-175,000
Supplemental Cash Flow Information